3-Phosphoglycerate
Reactions involving 3-Phosphoglycerate
Every recorded step where this molecule takes part
-
3-Phosphoglycerate + ATP → 1,3-bisphosphoglycerate + ADP
-
3-Phosphoglycerate → 2-phosphoglycerate
-
3-Phosphoglycerate ⇌ 2-phosphoglycerate
-
2-Phosphoglycerate ↔ 3-phosphoglycerate
-
1,3-Bisphosphoglycerate + ADP → 3-phosphoglycerate + ATP
-
1,3-Bisphosphoglycerate + ADP ⇌ 3-phosphoglycerate + ATP
Showing all 6 reactions.
Pathway junctions through this molecule
Produced in one pathway, consumed in another
| Produced in | Consumed in | Link | |
|---|---|---|---|
| Anaerobic Glycolysis / Lactic Acid Fermenta… | → | Gluconeogenesis | cross-category |
| Anaerobic Glycolysis / Lactic Acid Fermenta… | → | Glycolysis | cross-category |
| Gluconeogenesis | → | Anaerobic Glycolysis / Lactic Acid Fermenta… | cross-category |
| Gluconeogenesis | → | Glycolysis | within category |
| Glycolysis | → | Anaerobic Glycolysis / Lactic Acid Fermenta… | cross-category |
| Glycolysis | → | Gluconeogenesis | within category |
Recent literature
Europe PMC · fetched just now · sorted by publication date
-
1
Metabolic reprogramming in colorectal cancer: Mechanisms and therapeutic insights.
Xiao W, Tan D, Zeng W, Nie X, Wang M. · 2026-01-28
open access unreviewed -
2
Metabolic engineering of <i>Escherichia coli</i> based on adaptive evolution and omics technology for highly efficient l-valine production under oxygen-limited conditions.
Zhang H, Ha Z, Wei A, Zhao C, Meng G, Li X, Wu F, Liu J, Wu H, Ma Q, Xie X. · 2026-06-18
open access unreviewed -
3
Immunometabolism and rheumatic disease-advancing targeted therapies.
Boothby MR. · 2026-09-22
open access unreviewed -
4
The cervicovaginal gut microbiota axis as a key determinant of systemic physiology.
Rosenn EH, Zuniga M, Lipshitz M, Fox E, Engel M, Pasinetti GM. · 2026-09-21
open access unreviewed -
5
Isotopic tracing in <i>Mycobacterium tuberculosis</i>-infected alveolar epithelial cells indicates metabolic specificity to their virulence and drug-resistance status.
Akram S, Masakapalli SK, Nanda RK. · 2026-09-04
cited 1× open access unreviewed -
6
<i>Candida albicans</i> reprograms <i>Staphylococcus aureus</i> glycolytic metabolism to drive enhanced virulence.
Wan X, Wu Y, Yang Q, Wu R, Chen T, Luo Z. · 2026-09-04
open access unreviewed -
7
Decoding osteosarcoma pathogenesis: the pivotal influence of m<sup>6</sup>A modification.
Huang C, Han Z, Su J, Zhang M, Lin Y, He H, Tang Y, Guo P, Wang Y, Chen H. · 2026-07-21
open access unreviewed -
8
<i>Lactiplantibacillus plantarum</i> <sup>WJL</sup> ameliorates chronic kidney disease by inhibiting fibroblast growth factor 21 adaptive stress response via low protein diet.
Benoit B, Letourneau P, Verdier V, Viney A, Barnel C, Chikh K, Vitalis O, Jalabert A, Wagner S, Laiola M, Ale… · 2026-07-12
open access unreviewed -
9
Systems engineering of <i>Escherichia coli</i> for high-level hydroxytyrosol production.
Zuo J, Zhang S, Huang W, Liu J, Gao C, Hu GP, Song W, Li X, Wei W, Wu J, Liu L, Liu K, Xu N. · 2026-06-01
open access unreviewed -
10
Inhibitors of GapN-dependent NADPH supply as potential lead compounds for novel therapeutics against <i>Streptococcus pyogenes</i>.
Schütt I, Einwohlt P, Wandinger AM, Teuffel J, Wirsing R, Hlawatschke BH, Fehlauer HL, Bothe S, Bader N, Mona… · 2025-12-30
cited 2× open access unreviewed
External claims. These come from an index outside this database and are not checked against it. Treat them as leads.